FDA 483 - Cosway Company, Inc. - April 08, 2011

An FDA inspection of Cosway Company Inc. in Carson, CA, revealed significant deficiencies across its quality, laboratory, and production systems. Key issues included inadequate change control, deficient complaint record procedures, and failures in stability testing and cleaning validation. These observations indicate a lack of robust quality oversight and control in the manufacturing of pharmaceutical and cosmetic products.